Highlights
Profile claimed by owner
About
ML for Clinical Trial Optimization
PhaseV develops a platform for adaptive clinical trial design and closed-loop execution, leveraging an intuitive user interface and flexible software architecture along with cutting-edge algorithms such as reinforcement learning and causal ML to support key clinical decisions at any point during the trial.
Identity
| Name | PhaseV |
|---|---|
| Slug | phasev |
| Type / kind | startup |
| Source _id | 4eUUQhoI4wIQ36Qar8dyfuf3pNMKanhHsEjSkHF357eQP4R47pN78G |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Tel Aviv-Yafo |
| HQ address | Yigal Alon St 114, Tel Aviv-Yafo, Israel |
Web & social
| Website | https://www.phasevtrials.com |
|---|---|
| Careers page | https://www.linkedin.com/company/phasevtrials/jobs/ |
| https://www.linkedin.com/company/92848461 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical Workflow
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business models
B2B
Tags
data-science-platformclinical-trialslife-sciencesmachine-learning
Funding
| Total raised | $65.0M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}